Health Care & Life Sciences » Pharmaceuticals | Karolinska Development AB

Karolinska Development AB | Balance Sheet

Fiscal year is January-December. All values SEK Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
201
141
297
11
170
139
Net Property, Plant & Equipment
-
-
1
-
-
-
Total Assets
1,980
1,710
614
438
663
794
Other Liabilities
22
42
17
99
146
Total Liabilities
22
65
367
409
396
Common Equity (Total)
1,958
1,646
248
30
267
Total Shareholders' Equity
1,958
1,646
248
30
267
Total Equity
1,958
1,646
248
30
267
Liabilities & Shareholders' Equity
1,980
1,710
614
438
663
Short-Term Receivables
4
4
10
2
5
9
Investments - Total
-
1,552
307
425
488
646
Other Assets (Including Intangibles)
45
12
1
1
1
1
Investment in Unconsolidated Subs.
1,729
-
-
-
-
-
Total Debt
-
23
349
309
250

About Karolinska Development AB

View Profile
Address
Tomtebodavägen 23A
Solna AB 171 65
Sweden
Employees -
Website http://www.karolinskadevelopment.com
Updated 07/08/2019
Karolinska Development AB engages in the investment in pharmaceutical business. It invests in companies that develop medical innovations, specialty care products and orphan drugs for patients suffering from life-threatening and serious debilitating conditions. Its funds are obtained from independent investors and shareholders by issuing and selling shares and interest-bearing instruments.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.